Randomised Controlled Trial of the Diabetes Self-Management ‘Glucose Buddy’ Smartphone Application.

For an adult with Type 1 diabetes, does using a diabetes self-management smartphone application combined with text-message feedback improve glycemic control as compared to usual care.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612000132842

Enrollment

Registered

2012-01-30

Start date

2010-10-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In the study we trialled the effectiveness of a diabetes-related smart phone application to improve self-management and glycemic control in adult patients with T1DM. Specifically the aims of the project were to (i) trial the effectiveness of the ‘Glucose Buddy’ self-management application in improving glycemic control in adults with T1DM, (ii) trial the effectiveness of the ‘Glucose Buddy’ self-management application in producing relevant health behaviour change outcomes in adults with T1DM and, (iii) to examine the relationship of utilisation of the ‘Glucose Buddy’ application, patients engagement with the application and the level of self-care and glycemic control.

Interventions

Usual Care - 3-monthly visits to health care practitioner (general practitioner or endocrinologist) for 9-month duration of study. Plus Glucose Buddy iPhone App allows patients to enter in diabetes parameters (blood glucose, insulin, physical activity and diet). Text-message feedback from a Credentialed Diabetes Educator on a weekly basis for 6-months. Minimum of one text message a week, maximum of three. Feedback related to diabetes care - primarily stabilizing blood glucose levels.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

-Diagnosed with Type 1 Diabetes -Duration of disease > 6 months -Treated with multiple daily injections (MDI) or continuous subcutaneous insulin injections (Insulin Pump) -Inadequate glycemic control (HbA1c > 8%) -Own an iPhone and not currently using an iPhone application to self-monitor diabetes -Consent from patient and patient’s general practitioner to participate

Exclusion criteria

-Pregnant patients with Type 1 Diabetes -Early indicators of diabetes related complications: retinopathy, neuropathy, nephropathy and heart-disease General practitioner or endocrinologist of patient had to provide consent for their participation.

Outcome results